Best Alzheimer's and Dementia Research Grants in Louisiana

Early-career and postdoctoral Alzheimer’s disease researchers, including those based in Louisiana, can apply for BrightFocus Foundation’s Alzheimer’s Disease Research Grants, awarding US $200,000 - US $300,000 for pioneering studies. Funding supports projects that advance understanding, prevention, or treatment and can help launch or strengthen independent research careers in this field.

The JTMF Foundation Grant focuses on improving the lives of individuals in need, particularly in the Pacific Northwest. By partnering with organizations addressing immediate needs and long-term challenges, the foundation supports children, older adults, veterans, and individuals with intellectual and developmental disabilities. Guided by Catholic values, JTMF aims to empower communities while seeking innovative solutions to societal issues. Organizations that align with these focus areas are encouraged to connect, fostering a collaborative effort towards meaningful impact.

Louisiana nonprofits providing Alzheimer’s and dementia programs can access funding through the Alzheimer’s Foundation of America’s Bi-Annual Grant to support or expand services for individuals, families, and caregivers. AFA member organizations in good standing may receive US $6,000 for eligible costs such as staff, training, occupancy, supplies, and equipment.

Universities, research institutions, and similar organizations in Louisiana and other U.S. locations can access funding to run intensive postbaccalaureate research education programs in Alzheimer’s disease and related dementias. US Dept. of Health & Human Services: National Institutes of Health supports one-to-two-year mentored research experiences, offering up to US $400,000 for AD/ADRD projects tied to aging and career development.

Nonprofit or academic organizations running Alzheimer’s and dementia research education programs in Louisiana can apply for up to US $200,000 to offer summer research experiences. With a mission to expand the AD/ADRD workforce, National Institutes of Health provides support for hands-on STEM programs for high school students, undergraduates, or science teachers.

Louisiana dementia and Alzheimer’s disease researchers, especially early-career assistant professors (or equivalent) within seven years of appointment, can access funding through the Alzheimer’s Association to build preliminary or pilot data. Awards of US $70,000 - US $200,000 support diverse Alzheimer’s and related dementia studies, from basic science and biomarkers to clinical, psychosocial, and health equity research, with U.S. and international eligibility.

Louisiana nonprofits supporting dementia and Alzheimer’s care can access funding through Sephardic Home For The Aged Foundation to improve quality of life for older adults. Eligible 501(c)(3) organizations or those with a fiscal sponsor, operating at least two years, may receive support for innovative programs addressing dementia and related brain degenerative diseases.

Postdoctoral researchers conducting Alzheimer’s or dementia-related research in Louisiana can seek funding to advance understanding, diagnosis, or treatment, with awards up to US $200,000. The Alzheimer’s Association Research Fellowship for All supports early career investigators worldwide under established mentors, and encourages applications from individuals from underrepresented groups in dementia research.

Clinician scientists conducting dementia and Alzheimer’s disease research, including those based in Louisiana, can apply for the Alzheimer’s Association Clinician Scientist Fellowship for All, with awards up to US $250,000. Grants from Alzheimer’s Association help support licensed, practicing clinicians from diverse backgrounds pursuing careers in Alzheimer’s and related dementia research.

With a mission to support Alzheimer’s care and innovation, Alzheimer’s Foundation of America provides Louisiana dementia and Alzheimer’s nonprofits with US $25,000 for new programs that improve life for affected individuals and families. Only AFA nonprofit member organizations may apply, and funds can cover program-related admin costs, staff, training, travel, occupancy, supplies, and equipment.

Public safety agencies running dementia wandering-prevention or related public safety programs in Louisiana can apply for support, with awards around US $6,000 for training, equipment, administration, and community outreach. Focused on dementia and Alzheimer’s care and safety, the Alzheimer’s Foundation of America invites eligible Project Lifesaver International member agencies to strengthen local protections.

Nonprofit organizations providing dementia and Alzheimer’s respite care in Louisiana can apply for Alzheimer’s Foundation of America’s Milton & Phyllis Berg Family Respite Care Grants, with awards of US $6,000 to fund respite care scholarships. Eligible uses include supplies, equipment, capacity building, administrative expenses, and staff training that directly support respite programs.

Academic and medical research institutions conducting imaging-based Alzheimer’s and dementia studies in Louisiana can apply for this program, which offers US $200,000 for early-stage pilot projects. Grants from the Alzheimer’s Association help U.S. dementia researchers develop novel imaging tools and innovative imaging data analysis for Alzheimer’s and other neurodegenerative diseases over a one-year period.

Louisiana Alzheimer’s and dementia researchers studying olfactory decline and aging or Alzheimer’s/AD-related dementias can access funding via the National Institutes of Health. Focused on mechanisms linking smell loss with aging and disease, projects may use human or animal models and cellular, molecular, imaging, physiological, omics, or other innovative approaches.

Researchers studying dementia and Alzheimer’s disease in Louisiana can apply for National Institute on Aging R01 funding to investigate cerebellar contributions to cognitive and affective functions in healthy aging and AD/ADRD. Projects may use human or animal models, secondary data analyses, or explore cerebellar-targeted interventions to promote cognitive reserve or delay disease onset.

Families needing in-home respite care for loved ones with Alzheimer’s or other dementias can apply for the Margaret B. Moeller Memorial Fund for Alzheimer's Home Care Companions, with awards of US $200 - US $3,000 for companion or aide services. Louisiana dementia-focused nonprofits helping eligible families may be able to connect them to this support.

Louisiana Alzheimer’s and dementia research institutions can access funding through the National Institutes of Health for preclinical validation and early-stage drug discovery on novel therapeutic targets. This upcoming U01 opportunity from the National Institute on Aging supports rigorous AD and related dementias research across small molecules, biologics, and emerging therapeutic modalities, with nationwide eligibility including Louisiana organizations.

Research institutions and interdisciplinary consortia studying mechanisms of neurodegeneration in Alzheimer’s disease-related dementias can pursue collaborative “Center without Walls” funding, including teams in Louisiana. This National Institutes of Health initiative supports multi-site networks using advanced technologies, disease-relevant models, clinical science, and human specimens to uncover novel ADRD mechanisms, therapeutic targets, biomarkers, and factors influencing susceptibility and resilience.

Research institutions studying exposomic factors in Alzheimer’s disease-related dementias can apply for National Institutes of Health funding, with projects eligible from Louisiana and other U.S. locations. National Institutes of Health supports mechanistic, translational, and human subjects research on how environmental exposures and related pathways affect ADRD pathology, progression, resilience, and neurological health disparities.

Research institutions and teams studying Alzheimer’s disease-related dementias in Louisiana can apply for National Institutes of Health funding to conduct comprehensive functional validation of new therapeutic targets. This phased award supports technology and model development, then rigorous cross-validation across modalities and labs to de-risk future translational research and potential treatments.

Research institutions and eligible organizations in Louisiana studying dementia and Alzheimer’s care pathways and early detection can apply for the Alzheimer’s Association’s Health Services Research in Alzheimer’s Disease and Related Disorders program; awards up to US $250,000 support rigorous projects on detection, diagnosis, and post-diagnostic care to improve person-centered, coordinated brain health services.

The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) aims to create a secure, scalable cloud platform for genetic data related to Alzheimer’s disease. This initiative will enhance data accessibility, promote interoperability, and support rigorous research practices. By facilitating collaboration and providing robust analytical tools, the platform will maximize the scientific impact of AD/ADRD research, aligning with NIH goals for transparent and reproducible science, while addressing recommendations for broad access to high-value datasets.

The National Institute on Aging (NIA) is inviting applications for the Alzheimer's Drug-Development Program (U01 Clinical Trial Optional). This initiative seeks to support pre-clinical and early-stage clinical development of innovative drug candidates aimed at preventing Alzheimer's disease or treating its symptoms. The program encourages collaboration among researchers and aims to enhance the therapeutic pipeline for AD through targeted approaches. This notice allows potential applicants time to prepare robust projects.

The BJA FY 2026 Kevin and Avonte Program aims to reduce the injuries and fatalities of individuals with dementia and developmental disabilities who wander from safe environments. This funding opportunity supports law enforcement and public safety agencies in implementing locative technologies to track missing individuals and develop programs that enhance safety and facilitate rescues, ultimately ensuring the well-being of vulnerable populations.

The Barney Family Foundation Grant focuses on improving early education and advancing medical research, particularly in cancer and Alzheimer’s. It supports organizations that demonstrate a clear plan to enhance children's life experiences and educational opportunities for those in grades K-8. Grants typically range from $5,000 to $50,000, prioritizing established entities while welcoming startups. Eligible applicants must have 501(c)(3) status, and the Foundation does not fund individual requests or political activities.

The ADDF-Harrington Scholar Program aims to transform academic discoveries into effective treatments for Alzheimer’s disease and related dementias. With funding of up to $600,000 annually, this program prioritizes innovative drug targets and supports research from hit-to-lead optimization to IND-enabling studies. Eligible applicants include academic investigators with a strong potential to advance meaningful therapeutics. The program emphasizes collaboration with industry experts, making it a significant opportunity for advancing dementia research.